ClinicalTrials.Veeva

Menu

EBUS-TBNA vs Flex 19G EBUS-TBNA

H

Heidelberg University

Status

Unknown

Conditions

Sarcoidosis
Lung Cancer
Lymphoma
Lymphadenopathy

Treatments

Device: 21G EBUS-TBNA needle
Device: Flexible 19G EBUS-TBNA needle

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02916459
19G 1.1-2016

Details and patient eligibility

About

This is a prospective randomised diagnostic clinical study to determine whether the use of a new flexible sampling needle can improve the yield of endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA). Patients undergoing EBUS-TBNA for clinical reasons as deemed necessary by the managing physician or multidisciplinary team will be randomised to undergo either EBUS-TBNA or Flex 19G EBUS-TBNA. The procedure will be performed under local anaesthesia using conscious sedation or general anaesthesia according to usual practice at the trial centre. Specimens will be placed in saline and formalin and forwarded to the pathology laboratory. The specimens will be spun down to create a cell pellet which will undergo cytological and histological examination as per usual protocol at the trial centre.The pathologist, who will be blinded as to which technique was used to obtain the sample, will grade the quality, quantity, and cellularity of the specimens.

Enrollment

250 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Scheduled for EBUS-TBNA as part of clinical care
  2. Lymph nodes larger than 10mm in diameter
  3. Age > 18 years
  4. written informed consent

Exclusion criteria

  1. Contraindication to needle biopsy (e.g. coagulopathy, anticoagulation, thrombocytopenia)
  2. Inability to obtain informed consent

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

250 participants in 2 patient groups

EBUS-TBNA
Active Comparator group
Description:
Mediastinal and hilar lymph node sampling using a standard 21G EBUS-TBNA needle
Treatment:
Device: 21G EBUS-TBNA needle
Flex 19G EBUS-TBNA
Experimental group
Description:
Mediastinal and hilar lymph node sampling using the flexible 19G EBUS-TBNA needle
Treatment:
Device: Flexible 19G EBUS-TBNA needle

Trial contacts and locations

1

Loading...

Central trial contact

Felix Herth, Prof. Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems